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Objective: To demonstrate the effect of human umbilical cord blood-derived CD34þ cells on bladder
dysfunction induced by cerebral ischemia in rats.
Materials and Methods: Female rats were subjected to either 60 minute middle cerebral artery occlusion
(MCAO) or a sham operation. Rats were divided into four groups: sham operation, MCAO without
treatment, infusion with 1 106 CD34þ cells 30 minutes before MCAO, and infusion with 1 106 CD34þ
cells 3 hours after MCAO. Bladder function was analyzed by cystometry at 1 day, 3 days, and 7 days after
MCAO. Expressions of nerve growth factor (NGF), M2 and M3 muscarinic receptors were measured by
immunohistochemistry and real time polymerase chain reaction.
Results: Cystometric results showed that, following MCAO, rats have a signiﬁcant increase in peak
voiding pressure and residual volume. Conversely, there is a signiﬁcant decrease in voided volumes and
intercontraction intervals. Cystometric variables after pre- and postischemic CD34þ treatment nearly
returned to levels found in sham-operated rats. The expression of bladder NGF and M3 was decreased
after MCAO, but signiﬁcantly increased following preischemic CD34þ treatment. There was decreased
expression of bladder M2 mRNA despite an increased level of M2 immunoreactivity at 3 days and 7 days
after MCAO. Expression of bladder M2 immunoreactivity and mRNA nearly returned to sham group levels
after preischemic CD34þ treatment.
Conclusion: Bladder dysfunction in a rat model caused by MCAO may be restored to normal micturition
by treatment with human umbilical cord blood-derived CD34þ cells and may be related to the expres-
sions of NGF, M2, and M3 in the bladder.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Cerebral stroke has ranked as one of the leading causes of death
worldwide. Poststrokemortality and chronic neurological disability
are the result of neuronal damage for which there is currently no
effective preventive treatment. Recent data suggest that human
umbilical cord blood (HUCB)-derived CD34þ cells may promote
functional recovery in an animal model of stroke [1]. Several
mechanisms of HUCB recovery action were suggested includingand Gynecology, Chang Gung
n Street, Kweishan, Taoyuan
g).
bstetrics & Gynecology. Publishedreduction of damaged cells, recognization of nerve ﬁbers by trophic
actions, reduction in inﬂammatory response, and enhancement of
angiogenesis [1]. However, no study has been conducted to
demonstrate that HUCB-derived CD34þ cells can mediate thera-
peutic effects on bladder dysfunction following cerebral stroke,
although voiding dysfunction is common in patients with cere-
brovascular diseases.
Bladder overactivity induced by middle cerebral artery occlu-
sion (MCAO) in rats has been found to involve receptors in the brain
such as dopamine, glutamate, and gamma-aminobutyric acid
[2e6]. Nerve growth factor (NGF) and muscarinic receptors in
cerebral-infarcted rats also play a role in regulation of the mictu-
rition reﬂex in central and peripheral nervous systems [4,7,8]. There
is a signiﬁcant reduction of brain NGF after severe cerebral ischemiaby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
C.-C. Liang et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 672e679 673[7]. NGF has an effect on bladder dysfunction by mediating
morphological and functional changes in sensory neurons inner-
vating the bladder [8]. Muscarinic receptors in the brain contribute
to control of the micturition reﬂex [4]. A signiﬁcant increase in the
density of muscarinic receptors has been found in the urinary
bladder of cerebral-infarcted rats [9]. The present study was con-
ducted to evaluate whether: (1) the protective effect of HUCB-
derived CD34þ cells against cerebral vascular disease may
improve bladder dysfunction; and (2) HUCB-derived CD34þ cells
treatment may sustain the expression of NGF and muscarinic re-
ceptors in the bladder.
Materials and methods
Animal model
All protocols were approved by the Institutional Ethics Com-
mittee for the Care and Use of Experimental Animals and the
Institutional Review Board of Chang Gung Memorial Hospital
Linkou Medical Center, Taoyuan, Taiwan. Female Sprague Dawley
rats from the National Laboratory Animal Center (Taipei, Taiwan)
were maintained at 21e23C room temperatures and 47% humidity
with a 12-hour light-dark cycle with free access to standard labo-
ratory chow and tap water. Because endogenous estrogen may
improve stroke outcome during MCAO [10], all rats in this study
underwent bilateral ovariectomy performed 2 weeks before MCAO
to create a hypoestrogenic menopausal state. Rats were subjected
to either 60 minute MCAO or sham operation. All animalFigure 1. Cystometric results in the experimental rats (AeD) are presented (6 rats in each gr
volume (D) but signiﬁcant decrease in voided volume (B) and intercontraction interval (C)
sham-operated group, p< 0.05. Pretreatment: preischemic treatment, posttreatment: postisexperiments were conducted in accordance with the National In-
stitutes of Health Guide for the Care and Use of Laboratory Animals
(NIH Publications Number 80e23) revised 1996.
Clinically available tools such as recombinant tissue plasmin-
ogen activator were found to have a therapeutic window of 3e5
hours for the treatment of stroke [11]. In order to study the effect of
HUCB-derived CD34þ cells on the bladder dysfunction before and
after ischemic insult, 72 rats (270e320 g) were randomly assigned
to four groups: (1) sham operation; (2) rats with MCAO but no
CD34þ cells treatment; (3) rats infused with 1 106 CD34þ cells 30
minutes before MCAO (preischemic treatment group); and (4) rats
infused with 1 106 CD34þ cells 3 hours after MCAO (postischemic
treatment group). Bladder function was analyzed using conscious
cystometry at 1 day, 3 days, and 7 days after MCAO (6 rats in each
time point). Expressions of NGF, M2 muscarinic receptor (M2), and
M3 muscarinic receptor (M3) were measured by immunohisto-
chemistry and real time polymerase chain reaction (PCR).
Induction of cerebral ischemia
Left MCAO was used as an acute ischemic model according to
previously reported methods [12]. Rats were anesthetized with 2%
isoﬂurane in oxygen. Following satisfactory anesthesia, the prox-
imal portion of the external carotid artery was tightly ligated with a
silk suture. A 20 mm 4-0 nylon surgical thread was inserted from
the left external carotid artery into the internal carotid artery to
occlude the MCA. The left common carotid artery was then
permanently ligated and the wound was temporarily closed.oup). Ischemic rats show a signiﬁcant increase in peak voiding pressure (A) and residual
from 1 day to 7 days after middle cerebral artery occlusion (MCAO). *Compared with
chemic treatment.
Figure 2. Relative mRNA expression ratio of (A) nerve growth factor (NGF), (B) M2, and
(C) M3 (C) after middle cerebral artery occlusion (MCAO). The mRNA expressions of
NGF and M2 decrease after MCAO but increase at 7 days following preischemic CD34þ
cell treatment (6 rats in each group). M3 mRNA expression signiﬁcantly decreases after
MCAO but increases at 1 day and 3 days after CD34þ cell treatment. *Compared with
sham-operated group, p < 0.05. Pretreatment: preischemic treatment, posttreatment:
postischemic treatment.
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plete. After a 60-minute occlusion of the left MCA, rats were
reanesthetized, and the wound was opened to remove the nylon
surgical thread to allow for the reperfusion of the MCA. In the
sham-operated group, similar procedures were conducted without
ligation or occlusion of any vessel. Endovascular suture occlusion of
the MCA for 60 minutes would result in irreversible cerebral
ischemic injury in both the cerebral cortex and striatum [12].
Therefore, we only included animals that exhibited right side
weakness with upper limb dominance.
Preparation of CD34þ cells for transplantation
After informed consent, HUCB was obtained from healthy in-
dividuals using a VarioMACS Starting Kit (Miltenyi Biotec, Bergisteh
Gladbach, Germany) and CD34 MicroBead Kit (Miltenyi Biotec)
according to the manufacturer's protocol. The CD34þ cells were
collected and washed with phosphate-buffered saline (PBS) and
then prepared to a ﬁnal concentration of 1 106 cells/0.3 mL in PBS
[13]. In the CD34þ-treated groups, 1 106 collected CD34þ cells
were administered 30minutes before or 3 hours afterMCAO via the
tail vein under inhalation anesthesia.
Suprapubic tube implantation and cystometric studies
All rats received suprapubic tube implantation under isoﬂurane
general anesthesia 5 days prior to implementation of MCAO. The
animals were later placed in special metabolic cages (Med Associ-
ates, St. Albans, VT, USA) after MCAO to perform conscious cysto-
metric studies according to methods described in our previous
study [14]. Brieﬂy, the suprapubic catheter was connected to a sy-
ringe pump and pressure transducer. All bladder pressures were
referenced to air pressure at the level of the bladder. Pressure and
force transducer signals were ampliﬁed, recorded on a chart
recorder and digitized for data collection. The bladder was then
ﬁlled with room temperature 0.9% saline at 5 mL/h through the
bladder catheter while bladder pressure was recorded. Urine was
collected in a beaker on a balance placed beneath each cage.
Changes in the weight of the collection were recorded. Saline
infusion was continued until rhythmic bladder micturition con-
tractions became stable. After the initial stabilization period, data
for ﬁve representative micturition cycles were collected to analyze
all cystometric parameters. The following cystometric variables
were investigated: peak voiding pressure, intercontraction interval,
voided volume, and residual volume. Cystometry Analysis version
1.05 (Catamount Research and Development, St. Albans, Vermont,
USA) was used for cystometric analysis.
Immunohistochemistry
After cystometric studies were completed, the rats were sacri-
ﬁced and their bladders were harvested. The dissected bladders
were ﬁxed in an optimal cutting temperature compound, frozen in
powdered dry ice, and stored at 80C. The bladders were then
subjected to cryosectioning (10 mm) at 18C with the sections
mounted on glass microscope slides coated with saline (Muto Pure
Chemical, Tokyo, Japan).
Immunostaining against NGF, M2, and M3 in fresh-frozen
bladder sections was performed with an avidin-biotin peroxidase
method using a kit (PK-6102, Vector Laboratories, Burlingame, CA,
USA). First, fresh-frozen sections were ﬁxed in 4% para-
formaldehyde for 10 minutes, air dried, and then rinsed with PBS.
After blocking with Dako REAL peroxidase blocking solution (code
S2023, DAKO Corporation, Carpinteria, CA, USA) for 20 minutes,
sections were washed and incubated for 18e20 hours at 4C with a
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(Chemicon International, Temecula, CA, USA) or rabbit polyclonal
antibody directed against M2 and M3 at a 1:2000 dilution (Chem-
icon International). Endogenous peroxidase was blocked for 10
minutes with 0.2% H2O2 and 100% methanol. Then, sections were
washed and incubated for 1 hour using biotinylated anti-rabbit
immunoglobulin G antibody for NGF, M2, and M3 at a 1:500 dilu-
tion (Vector Laboratories). This was followed by incubation for 1
hour with avidin-biotin-horseradish peroxidase complex at a 1:100
dilution. Staining was developed with 3,30-diaminobenzidine plus
hydrogen peroxide as the chromogen. All incubations were per-
formed at room temperature except for the use of primary anti-
body. Negative control slides were prepared from the same tissue
blocks by omitting the speciﬁc primary antibodies and using
normal, nonimmune serum supernatant from the same sources.
The ratio of the optical density of no treatment, pre-, or post-
treatment MCAO rat to that of sham-operated rat was determined
in NGF, M2, and M3 analyses. Image-Pro Plus Software (Media Cy-
bernetics, Silver Spring, MD, USA) was used for immunohisto-
chemical measurement calculations.Figure 3. Temporal expressions of nerve growth factor (NGF) immunoreactivity in middle c
immunoreactivity decreases at 3 days and 7 days after MCAO, but signiﬁcantly increases fol
operated group, p < 0.05. Pretreatment: preischemic treatment, posttreatment: postischemReal-time PCR
Real time PCR was carried out according to the manufacturer's
protocol. Total RNAs were prepared using a Trizol reagent (Invi-
trogen, Carlsbad, CA, USA) and incubated in reverse transcription
mixture at 25C for 5 minutes, 50C for 1 hour, and 70C for 15
minutes; ﬁnally, the tubes were cooled to 4C for 5 minutes. Gene
expression for NGF, M2, and M3 in the bladder tissue was analyzed
by real time PCR using inventoried TaqMan assays from Applied
Biosystems (Life Technologies, Grand Island, NY, USA). The NGF,
M2, and M3 assays codes were Rn01533872-m1, Rn02532311-s1,
and Rn00560986-s1, respectively (Applied Biosystems).
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) assays
codes (Rs99999916-s1) were used as an endogenous control to
allow for quantiﬁcation of relative gene expression. Thermal
cycling and ﬂuorescence detection were performed using an ABI
Prism 7900HT Sequence Detection System (Applied Biosystems).
PCR conditions were 50C for 2 minutes, 95C for 10 minutes,
followed by 40 cycles at 95C for 15 seconds and 60C for 1
minute.erebral artery occlusion (MCAO) rat bladder (6 rats in each group). Expression of NGF
lowing preischemic CD34þ cell treatment. Bar indicates 20 mm. *Compared with sham-
ic treatment.
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[15]. A ratio of the mRNA level of ischemic rats to that of sham-
operated rats was determined. The values were summed and
expressed as mean± standard deviation and were compared sta-
tistically among sham operation and each time point in each group.
Statistical analysis
The data were analyzed statistically using one-way analysis of
variance test followed by a Tukey test. Values were considered
signiﬁcant at p< 0.05. Prism 5 software for statistical analysis
(GraphPad, San Diego, CA, USA) was used for all data.
Results
Cystometric results showed ischemic rats have an increase in
peak voiding pressure and residual volume at 1 day, 3 days, and 7Figure 4. Temporal expressions of M2 immunoreactivity in middle cerebral artery occlusion
at 3 days and 7 days after MCAO, but declines to the levels of the sham-operated group after
Pretreatment: preischemic treatment, posttreatment: postischemic treatment.days following MCAO, which declined after pre- and postischemic
CD34þ cells treatment (Figure 1). Voided volumes and intercon-
traction intervals signiﬁcantly decreased after MCAO, but increased
after pre- and postischemic CD34þ cells treatment at 3 days and 7
days.
The mRNA expressions of NGF and M2 decreased after MCAO,
but increased at 7 days following preischemic CD34þ cell treatment
(Figure 2). M3 mRNA expression signiﬁcantly decreased after
MCAO, but increased at 1 day and 3 days after CD34þ cell treatment.
Expression of NGF immunoreactivity decreased at 3 days and 7
days after MCAO, but signiﬁcantly increased following preischemic
CD34þ cell treatment (Figure 3). Expression of M2 immunoreac-
tivity increased at 3 days and 7 days afterMCAO, but declined to the
levels of the sham-operated group after CD34þ treatment
(Figure 4). Expression of M3 immunoreactivity signiﬁcantly
decreased at 1 day, 3 days, and 7 days after MCAO, but increased
after CD34þ cell treatment (Figure 5). Unlike the effect of(MCAO) rat bladder (6 rats in each group). Expression of M2 immunoreactivity increases
CD34þ treatment. Bar indicates 20 mm. *Compared with sham-operated group, p< 0.05.
Figure 5. Temporal expressions of M3 immunoreactivity in middle cerebral artery occlusion (MCAO) rat bladder (6 rats in each group). Expression of M3 immunoreactivity
signiﬁcantly decreases at 1 day, 3 days, and 7 days after MCAO but increases after CD34þ cell treatment. Bar indicates 20 mm. *Compared with sham-operated group, p< 0.05.
Pretreatment: preischemic treatment, posttreatment: postischemic treatment.
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transplantation did not upregulate the expression of NGF, M2, and
M3 mRNA to the levels of the sham group at 7 days after MCAO.
Discussion
Voiding dysfunction is a common sequela of cerebral stroke [16].
Maruyama et al [9] reported that rats with cerebral infarction show
a signiﬁcant decrease in bladder capacity, resulting in a shortening
of the micturition interval and a decrease in voided volume. The
bladder capacity of cerebral-infarcted rats is signiﬁcantly reduced
whichmay bemediated by twomechanisms: (1) upregulation of an
excitatory pathway from the forebrain; and (2) downregulation of a
tonic inhibitory pathway from the forebrain [3]. Vendrame et al [17]
measured infarct volume in an MCAO rat stroke model and
demonstrated a dose relationship between HUCB cells, behavioral
improvement, and neural sparing. However, no study has reported
that HUCB cells can mediate therapeutic effects on bladderdysfunction after stroke. The cystometric data in the present study
showed that rats undergoing MCAO have a signiﬁcant increase in
peak voiding pressure and residual volume. Conversely, voided
volumes and intercontraction intervals signiﬁcantly decrease after
MCAO, but variables of urodynamic testing return to the levels of
sham-operated rats after HUCB-derived CD34þ cell treatment.
NGF is normally present in bladder muscle cells and urothelium
[18]. Previous study showed that bilateral vesical artery ligation in
rats may cause damage of detrusor muscle and there is decreased
NGF immunoﬂuorescence and elevated NGF mRNA in bladder [19].
Liang et al [14] found that NGF immunoreactivity and mRNA in the
bladder muscle were transiently increased at 1 day, and declined
signiﬁcantly at 7 days and 28 days after bilateral common carotid
artery occlusion in rats. The current results demonstrate that the
decrease in bladder NGF immunoreactivity and mRNA expression
that occurs in rats 3e7 days after MCAO can be reversed to an in-
crease in NGF expression following preischemic CD34þ cell treat-
ment, due to an amelioration of the ischemic insult of brain. A
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ripheral NGF levels [20]. Serum NGF levels were signiﬁcantly
related to stroke severity and the volume of brain infarction in the
immediate poststroke period [20].
Rat bladder muscle is enriched with muscarinic receptors [21].
The mechanism underlying the regulation of muscarinic receptors
in the bladder following cerebral infarction is still unclear. Some
authors have suggested that cerebral infarction reduces para-
sympathetic tone in the bladder, thereby inducing compensatory
upregulation of muscarinic receptors [9]. Results of our study show
that expression of M2 immunoreactivity in the bladder is increased,
but M3 immunoreactivity is decreased in the 7 days after MCAO. M3
receptors are a minority population in this tissue, but they have
been shown to play a predominant role in mediating most of the
detrusor contractility under normal physiological conditions
[22,23]. However, when compared with normal controls, there is a
50% increase in total receptor density and a 60% increase in M2 but
not M3 receptor density in the denervated bladder [24]. Spinal cord
injury in the rat may induce bladder hypertrophy and a change in
muscarinic receptor subtype fromM3 towardM2 [25]. Our data also
reveal that the expression of M2 mRNA and M3 mRNA in the
bladder decreases after MCAO in the untreated group. However,
this expression may return to sham group levels after preischemic
CD34þ cell treatment.
In previous studies, systemic administration of HUCB-derived
CD34þ cells to MCAO rodents has been found to induce the neo-
vascularization in the ischemic zone that is essential for neuronal
regeneration and functional recovery after stroke [1]. Only a few
studies regarding stem cell treatment in bladder diseases have been
conducted [26e28]. Some investigators have reported that local
injection of muscle-derived [28] or bone marrow stem cells may
ameliorate impaired detrusor contractility in injured bladder ro-
dent models [26,27]. However, adult stem cells from bone marrow
and muscle are difﬁcult to obtain, and they have the disadvantages
of restricted differentiation potential, decreasing number with age,
and a shorter life span compared with HUCB or amniotic ﬂuid stem
cells [29].
This study has some limitations. First, the present study did not
demonstrate the therapeutic effect of CD34þ cells on behavior
recovery and on the infarct size in the ischemic brain. Further
study is needed to illustrate the mechanism of neuroprotection by
CD34þ cells, which may promote hemodynamic and functional
recovery of the brain after MCAO. Second, we did not use the
menopausal rats instead of bilateral ovariectomized rats. Third,
bladder injection of CD34þ cells may improve bladder dysfunction
induced by MCAO. Future research on this topic deserves to be
conducted.
In conclusion, the present study shows that MCAO in rats results
in changes of bladder NGF and muscarinic receptors and that such
regulation of bladder receptors may be at least partly associated
with the symptoms of bladder dysfunction induced by cerebral
infarction. Our results demonstrate that bladder dysfunction in a
rat model caused by MCAO may be restored to normal micturition
by treatment with HUCB-derived CD34þ cells and that this
improvement may be related to the expression of NGF, M2, and M3
in the bladder.
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